Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.
Townsley CA, Major P, Siu LL, Dancey J, Chen E, Pond GR, Nicklee T, Ho J, Hedley D, Tsao M, Moore MJ, Oza AM.
Townsley CA, et al.
Br J Cancer. 2006 Apr 24;94(8):1136-43. doi: 10.1038/sj.bjc.6603055.
Br J Cancer. 2006.
PMID: 16570047
Free PMC article.
Clinical Trial.